Statistics

Total Visits

Views
A multicenter randomized study comparing temozolomide (TMZ) versus TMZ-plus-bevacizumab (BEV) before standard treatment in unresectable glioblastoma (GBM) patients (p): The GENOM 009 study by the GEINO group19

Select a period of time:

Number of views in the range

Views
A multicenter randomized study comparing temozolomide (TMZ) versus TMZ-plus-bevacizumab (BEV) before standard treatment in unresectable glioblastoma (GBM) patients (p): The GENOM 009 study by the GEINO group9

Views

Views
May 20243
June 20242
July 20241
August 20241
September 20241
October 20240
November 20241
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States9
 

Top cities views

Views
Chicago4